000 01361 a2200409 4500
005 20250512065722.0
264 0 _c19860707
008 198607s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm00156a012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNicolaides, E D
245 0 0 _aModified di- and tripeptides of the C-terminal portion of oxytocin and vasopressin as possible cognition activation agents.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cJun 1986
300 _a959-71 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCognition
_xdrug effects
650 0 4 _aMacaca mulatta
650 0 4 _aMemory, Short-Term
_xdrug effects
650 0 4 _aOxytocin
_xpharmacology
650 0 4 _aPeptides
_xchemical synthesis
650 0 4 _aRats
650 0 4 _aStructure-Activity Relationship
650 0 4 _aVasopressins
_xpharmacology
700 1 _aTinney, F J
700 1 _aKaltenbronn, J S
700 1 _aRepine, J T
700 1 _aDeJohn, D A
700 1 _aLunney, E A
700 1 _aRoark, W H
700 1 _aMarriott, J G
700 1 _aDavis, R E
700 1 _aVoigtman, R E
773 0 _tJournal of medicinal chemistry
_gvol. 29
_gno. 6
_gp. 959-71
856 4 0 _uhttps://doi.org/10.1021/jm00156a012
_zAvailable from publisher's website
999 _c3718087
_d3718087